ArticleJournal of translational medicine2025

CD155 reprograms glycolysis via the YAP/TEAD1-GLUT1 axis to promote lung adenocarcinoma progression and M2 macrophage polarization: a metabolic-immune target visualized by

Zhiming Cheng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.